Top 30 Companies in Global Interventional Pulmonology Market (2024–2035): Competitive Analysis & Forecast
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
The global interventional pulmonology market encompasses minimally invasive procedures used for the diagnosis and treatment of pulmonary diseases, including lung cancer, airway obstructions, and pleural disorders. It involves advanced techniques such as bronchoscopy, endobronchial ultrasound, and image-guided interventions, enabling precise and efficient respiratory care. Market growth is primarily driven by the rising incidence of chronic respiratory conditions, increasing preference for minimally invasive procedures, and continuous technological advancements in diagnostic and therapeutic devices. The growing aging population and improvements in healthcare infrastructure further support market expansion. Significant opportunities exist in emerging economies due to improving access to healthcare services, increasing awareness of early disease detection, and rising investments in advanced medical technologies. Additionally, integration of artificial intelligence in diagnostic procedures is expected to enhance clinical outcomes. Recent developments include the introduction of advanced robotic bronchoscopy systems and strategic collaborations among key players to expand product portfolios and strengthen global presence.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global interventional pulmonology market.
Market Segmentation
Global Interventional Pulmonology Market Size, Share, and, By Product Type (Bronchoscopes, Endobronchial Ultrasound (EBUS) Systems, Biopsy Devices, Ablation Devices, and Accessories), By Procedure Type (Bronchoscopy, Thoracoscopy, Pleuroscopy, and Others), By Indication (Lung Cancer, Chronic Obstructive Pulmonary Disease (COPD), Asthma, Pulmonary Fibrosis, and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa), Analysis and Forecast 2024 – 2035.
Global Interventional Pulmonology Market Size & Statistics
- The market size for Global Interventional Pulmonology was estimated to be worth USD 4.19 billion in 2024.
- The market is going to expand at a CAGR of 8.15% between 2024 and 2035.
- The Global interventional pulmonology market size is anticipated to reach USD 9.92 billion by 2035.
- North America is expected to generate the largest revenue during the forecast period in the Global Interventional Pulmonology market
- Asia Pacific is expected to grow at the fastest rate during the forecast period in the Global interventional pulmonology market.
Regional growth and demand
Asia Pacific is expected to grow at the fastest rate during the forecast period in the global interventional pulmonology market. Asia Pacific is expected to grow at the fastest rate due to rapidly improving healthcare infrastructure and increasing healthcare expenditure across emerging economies such as China and India. The rising burden of respiratory diseases, coupled with growing awareness regarding early diagnosis, is accelerating demand for advanced pulmonary interventions. Additionally, the expansion of private healthcare providers and increased adoption of minimally invasive technologies further support regional growth. Favorable government initiatives aimed at strengthening healthcare systems also contribute to the region’s strong growth trajectory.
North America is expected to generate the largest revenue during the forecast period in the global interventional pulmonology market. North America is expected to generate the highest revenue due to the high prevalence of lung diseases and well-established healthcare infrastructure. The region benefits from early adoption of advanced technologies, a strong presence of key market players, and significant investment in research and development. Moreover, favorable reimbursement policies and high healthcare spending enable widespread access to innovative diagnostic and therapeutic procedures, reinforcing its leading market share.
Ready to lead the Global Interventional Pulmonology Market
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the Global Interventional Pulmonology Market
- Increasing Adoption of Minimally Invasive Procedures
- Advancements in Robotic-Assisted Bronchoscopy
- Integration of Artificial Intelligence in Diagnostics
- Rising Use of Endobronchial Ultrasound (EBUS) Systems
- Growing Focus on Early Lung Cancer Detection
- Expansion of Outpatient and Ambulatory Care Settings
- Technological Innovations in Biopsy and Ablation Devices
- Increasing Healthcare Investments in Emerging Economies
- Development of Personalized and Precision Medicine Approaches
- Strategic Collaborations and Partnerships Among Key Players
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global interventional pulmonology market.
1. Increasing Adoption of Minimally Invasive Procedures
The growing preference for minimally invasive procedures is a key trend shaping the interventional pulmonology market. These procedures offer reduced patient trauma, shorter hospital stays, and faster recovery times compared to traditional surgical methods. Healthcare providers are increasingly adopting bronchoscopy techniques to manage complex pulmonary conditions with improved precision and safety. This shift is also supported by advancements in imaging technologies, which enhance procedural accuracy. Furthermore, patient awareness regarding less invasive treatment options continues to rise, contributing to increased demand. As healthcare systems aim to improve efficiency and outcomes, minimally invasive approaches are expected to remain central to market growth.
2. Advancements in Robotic-Assisted Bronchoscopy
Robotic-assisted bronchoscopy is transforming pulmonary diagnostics and treatment by enabling greater precision and control during procedures. These systems allow clinicians to access peripheral lung lesions that were previously difficult to reach using conventional techniques. The technology enhances diagnostic yield while reducing complications, making it particularly valuable in early-stage lung cancer detection. Continuous innovation in robotic platforms is improving navigation, visualization, and procedural efficiency. Additionally, increasing investments by medical device companies are accelerating the commercialization of these systems. As clinical evidence supporting their effectiveness grows, robotic-assisted bronchoscopy is expected to gain widespread adoption across advanced healthcare settings.
3. Integration of Artificial Intelligence in Diagnostics
Artificial intelligence is increasingly being integrated into interventional pulmonology to improve diagnostic accuracy and workflow efficiency. AI-powered tools assist in analyzing imaging data, detecting abnormalities, and guiding biopsy procedures with greater precision. These technologies help clinicians identify early-stage lung diseases, including cancer, which significantly improves patient outcomes. Machine learning algorithms are also being used to enhance decision-making and reduce diagnostic variability. The adoption of AI is further supported by the growing availability of large clinical datasets and advancements in computing capabilities. As regulatory approvals expand, AI integration is expected to become a standard component of pulmonary diagnostics.
4. Rising Use of Endobronchial Ultrasound (EBUS) Systems
Endobronchial ultrasound (EBUS) systems are gaining significant traction as a minimally invasive diagnostic tool for evaluating lung and mediastinal conditions. EBUS enables real-time imaging and guided tissue sampling, improving the accuracy of lung cancer staging and diagnosis. The technique reduces the need for more invasive surgical procedures, thereby lowering associated risks and healthcare costs. Increasing clinical preference for EBUS is driven by its effectiveness, safety profile, and ability to provide rapid results. Moreover, ongoing technological improvements are enhancing image quality and procedural capabilities. As awareness and training increase, the adoption of EBUS systems is expected to expand globally.
5. Growing Focus on Early Lung Cancer Detection
Early detection of lung cancer is becoming a critical focus area in interventional pulmonology, driven by the need to improve survival rates and reduce treatment costs. Advanced diagnostic tools, including low-dose imaging and bronchoscopy techniques, are enabling the identification of malignancies at earlier stages. Healthcare systems and governments are increasingly promoting screening programs, particularly for high-risk populations such as smokers. This trend is supported by technological innovations that enhance sensitivity and specificity in detection methods. As awareness continues to grow, early diagnosis is expected to play a pivotal role in shaping future clinical practices and market demand.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the global interventional pulmonology market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global interventional pulmonology market.
Top 30 Companies Leading the Global Interventional Pulmonology Market
- Olympus Corporation
- Boston Scientific Corporation
- Medtronic plc
- Fujifilm Holdings Corporation
- Johnson & Johnson
- Ambu A/S
- Becton, Dickinson and Company
- Cook Medical
- KARL STORZ SE & Co. KG
- Pentax Medical
- Richard Wolf GmbH
- Teleflex Incorporated
- ConMed Corporation
- Broncus Medical Inc.
- Vygon SAS
- Argon Medical
- Taewoong Medical Co., Ltd.
- Shanghai Aohua Endoscopy
- Hunan Vathin Medical
- Huger Medical Instrument
- Intuitive Surgical, Inc.
- Pulmonx Corporation
- Merit Medical Systems
- Body Vision Medical
- Noah Medical
- Veran Medical Technologies
- Biodesix
- Erbe Elektromedizin GmbH
- ENDO-FLEX GmbH
- Rocket Medical plc
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global interventional pulmonology market.
1. Olympus Corporation
Headquarters: Tokyo, Japan
Olympus Corporation, active in over 100 countries, is a leading provider of endoscopic solutions with a dominant presence in interventional pulmonology. The company specializes in advanced bronchoscopes, endobronchial ultrasound systems, and imaging technologies that support accurate diagnosis and minimally invasive procedures. Its strong global distribution network and continuous focus on innovation enable widespread adoption across hospitals and specialty clinics. Olympus plays a critical role in advancing pulmonary care by enhancing visualization, procedural precision, and clinical outcomes, making it a cornerstone player in the global interventional pulmonology landscape.
2. Boston Scientific Corporation
Headquarters: Marlborough, Massachusetts, USA
Boston Scientific Corporation, active in more than 100 countries, is a major player in interventional medical devices with a strong footprint in pulmonary interventions. The company offers a wide range of products including biopsy tools, airway stents, and ablation systems designed for minimally invasive respiratory procedures. Its emphasis on technological advancement and physician-focused solutions strengthens its position in complex pulmonary treatments. Boston Scientific continues to expand its global presence through innovation and strategic collaborations, contributing significantly to improved patient outcomes in interventional pulmonology worldwide.
3. Medtronic plc
Headquarters: Dublin, Ireland
Medtronic plc, operating in over 150 countries, is a global leader in medical technology with a diversified portfolio that includes respiratory and interventional solutions. In interventional pulmonology, the company provides advanced navigation systems and minimally invasive tools that support precise diagnosis and treatment of lung diseases. Its strong focus on research and development, combined with a broad global reach, enables consistent adoption across developed and emerging markets. Medtronic’s commitment to innovation and integrated healthcare solutions strengthens its role in enhancing pulmonary care and expanding access to advanced procedures worldwide.
4.Fujifilm Holdings Corporation
Headquarters: Tokyo, Japan
Fujifilm Holdings Corporation, active in more than 100 countries, has established a strong presence in medical imaging and endoscopic technologies. The company offers high-quality bronchoscopes and advanced imaging systems that support early detection and minimally invasive treatment of respiratory conditions. Leveraging its expertise in optics and digital imaging, Fujifilm enhances diagnostic accuracy and procedural efficiency. Its expanding healthcare portfolio and global distribution capabilities enable it to serve a wide range of clinical settings, reinforcing its position as a key contributor to the advancement of interventional pulmonology.
5. Johnson & Johnson
Headquarters: New Brunswick, New Jersey, USA
Johnson & Johnson, active in over 100 countries, participates in interventional pulmonology through its Ethicon division and the Monarch robotic platform. The company focuses on robotic-assisted bronchoscopy, enabling enhanced navigation and precision in lung procedures, particularly for early-stage cancer diagnosis. Its strong global infrastructure and emphasis on innovation support the integration of advanced technologies into clinical practice. By combining robotics with minimally invasive techniques, Johnson & Johnson is contributing to the evolution of pulmonary interventions and improving procedural outcomes across global healthcare systems.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global interventional pulmonology market.
Are you ready to discover more about the global interventional pulmonology market?
The report provides an in-depth analysis of the leading companies operating in the global interventional pulmonology market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
1.Olympus Corporation
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
2.Boston Scientific Corporation
3.Medtronic plc
4.Fujifilm Holdings Corporation
5.Johnson & Johnson
6.Ambu A/S
7.Becton, Dickinson and Company (BD)
8.Cook Medical
9.KARL STORZ SE & Co. KG
10.Others.
Conclusion
The global interventional pulmonology market is witnessing steady growth, driven by the increasing prevalence of respiratory diseases, rising demand for minimally invasive procedures, and continuous technological advancements in diagnostic and therapeutic devices. Interventional pulmonology offers precise, efficient solutions for conditions such as lung cancer and airway disorders, improving patient outcomes and reducing recovery time. Innovations in robotic bronchoscopy, advanced imaging, and navigation systems further enhance procedural accuracy and clinical effectiveness. Leading companies such as Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Fujifilm Holdings Corporation, and Ambu A/S are expanding their global presence, contributing to market development. Overall, interventional pulmonology plays a crucial role in advancing modern respiratory care worldwide.
Other Indusrty Reports :
Airborne Electronic Warfare Market Trends ,Forecast Report 2035
Computer Aided Detection (CAD) Market Trends, Outlook Report 2035
Ebola Vaccine Market Trends, Forecast Report 2035
Custom Software Development Market Trends, Forecast Report 2035
Delta Robots Market Trends, Forecast Report 2035
Airborne Electronic Warfare Market Trends ,Forecast Report 2035
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?